Asim Alam1,2,3, David N Juurlink4,5,6. 1. Department of Anesthesia, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada. asim.alam@sunnybrook.ca. 2. Trauma, Emergency and Critical Care Program, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. asim.alam@sunnybrook.ca. 3. Department of Anesthesia, University of Toronto, Toronto, ON, Canada. asim.alam@sunnybrook.ca. 4. Department of Medicine, University of Toronto, Toronto, ON, Canada. 5. Department of Pediatrics, University of Toronto, Toronto, ON, Canada. 6. Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Abstract
PURPOSE: The objectives for preparing this article were to review the historical context and epidemiology surrounding the North American prescription opioid crisis, to summarize the evidence regarding the benefits and harms of long-term opioid therapy for non-cancer pain, and to outline ways in which anesthesiologists may help ameliorate the problem. SOURCE: We searched PubMed, Google Scholar, and EMBASE™ for relevant articles using various search terms, including pain, opioid epidemic, history of opioid use, perioperative care, and addiction. Related citations were further explored and searched depending on the specific subtopic of interest. PRINCIPAL FINDINGS: In the 1980s and early 1990s, opioids were infrequently used for the treatment of chronic pain. Thereafter, however, physicians were gradually inculcated with the message that long-term opioid therapy was a safe and effective treatment option for patients with chronic non-cancer pain. Pharmaceutical companies supported this growing movement and employed aggressive and sometimes misleading marketing strategies for new opioid formulations. As a result, the practice of prescribing opioids flourished in the late 1990s. The surge in prescribing opioids was accompanied by a marked increase in opioid-related morbidity and mortality. This change in practice transpired despite the absence of randomized trials showing clinically significant benefit from the long-term use of opioids. Subsequently, however, a large and growing body of evidence has emerged quantifying the harms associated with long-term opioid therapy. Anesthesiologists widely prescribe opioids for acute and chronic pain; yet, as a group, they may be largely unaware of the current state of this growing epidemic and what role they can play to rectify this problem. CONCLUSION: Anesthesiologists are well positioned to take a leadership role in the management of postoperative discharge opioid therapy in an effort to curb the overutilization of opioids. Furthermore, anesthesiologists who regularly prescribe opioids for chronic pain patients should appreciate the limited evidence base for this practice and communicate the risks of opioid therapy to their patients.
PURPOSE: The objectives for preparing this article were to review the historical context and epidemiology surrounding the North American prescription opioid crisis, to summarize the evidence regarding the benefits and harms of long-term opioid therapy for non-cancer pain, and to outline ways in which anesthesiologists may help ameliorate the problem. SOURCE: We searched PubMed, Google Scholar, and EMBASE™ for relevant articles using various search terms, including pain, opioid epidemic, history of opioid use, perioperative care, and addiction. Related citations were further explored and searched depending on the specific subtopic of interest. PRINCIPAL FINDINGS: In the 1980s and early 1990s, opioids were infrequently used for the treatment of chronic pain. Thereafter, however, physicians were gradually inculcated with the message that long-term opioid therapy was a safe and effective treatment option for patients with chronic non-cancer pain. Pharmaceutical companies supported this growing movement and employed aggressive and sometimes misleading marketing strategies for new opioid formulations. As a result, the practice of prescribing opioids flourished in the late 1990s. The surge in prescribing opioids was accompanied by a marked increase in opioid-related morbidity and mortality. This change in practice transpired despite the absence of randomized trials showing clinically significant benefit from the long-term use of opioids. Subsequently, however, a large and growing body of evidence has emerged quantifying the harms associated with long-term opioid therapy. Anesthesiologists widely prescribe opioids for acute and chronic pain; yet, as a group, they may be largely unaware of the current state of this growing epidemic and what role they can play to rectify this problem. CONCLUSION: Anesthesiologists are well positioned to take a leadership role in the management of postoperative discharge opioid therapy in an effort to curb the overutilization of opioids. Furthermore, anesthesiologists who regularly prescribe opioids for chronic painpatients should appreciate the limited evidence base for this practice and communicate the risks of opioid therapy to their patients.
Authors: Catherine L Chen; Molly Moore Jeffery; Erin E Krebs; Cornelius A Thiels; Mark A Schumacher; Adam J Schwartz; Robert Thombley; Emily Finlayson; Rosa Rodriguez-Monguio; Derek Ward; R Adams Dudley Journal: J Am Acad Orthop Surg Glob Res Rev Date: 2020-01-07
Authors: Jennifer M Joseph; Davide Gori; Catherine Curtin; Jennifer Hah; Vy Thuy Ho; Steven M Asch; Tina Hernandez-Boussard Journal: Surgery Date: 2021-09-15 Impact factor: 3.982
Authors: Karishma Desai; Ian Carroll; Steven M Asch; Tina Seto; Kathryn M McDonald; Catherine Curtin; Tina Hernandez-Boussard Journal: J Surg Res Date: 2018-04-11 Impact factor: 2.192
Authors: Elena J Koepke; Erin L Manning; Timothy E Miller; Arun Ganesh; David G A Williams; Michael W Manning Journal: Perioper Med (Lond) Date: 2018-07-03